BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 16001329)

  • 1. Menin molecular interactions: insights into normal functions and tumorigenesis.
    Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
    Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
    Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.
    Corbo V; Dalai I; Scardoni M; Barbi S; Beghelli S; Bersani S; Albarello L; Doglioni C; Schott C; Capelli P; Chilosi M; Boninsegna L; Becker KF; Falconi M; Scarpa A
    Endocr Relat Cancer; 2010 Sep; 17(3):771-83. PubMed ID: 20566584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.
    Hussein N; Casse H; Fontanière S; Morera AM; Asensio MJ; Bakeli S; Lu JL; Coste I; Di Clemente N; Bertolino P; Zhang CX
    Eur J Cancer; 2007 Jan; 43(2):402-14. PubMed ID: 17184987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.
    Wautot V; Vercherat C; Lespinasse J; Chambe B; Lenoir GM; Zhang CX; Porchet N; Cordier M; Béroud C; Calender A
    Hum Mutat; 2002 Jul; 20(1):35-47. PubMed ID: 12112656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
    Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
    Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN1 tumor-suppressor protein localizes to telomeres during meiosis.
    Suphapeetiporn K; Greally JM; Walpita D; Ashley T; Bale AE
    Genes Chromosomes Cancer; 2002 Sep; 35(1):81-5. PubMed ID: 12203793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menin and its interacting proteins: elucidation of menin function.
    Balogh K; Rácz K; Patócs A; Hunyady L
    Trends Endocrinol Metab; 2006 Nov; 17(9):357-64. PubMed ID: 16997566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
    Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
    Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 1: a chromatin writer's block.
    Dreijerink KM; Lips CJ; Timmers HT
    J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable overexpression of MEN1 suppresses tumorigenicity of RAS.
    Kim YS; Burns AL; Goldsmith PK; Heppner C; Park SY; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ
    Oncogene; 1999 Oct; 18(43):5936-42. PubMed ID: 10557080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.
    Ohkura N; Kishi M; Tsukada T; Yamaguchi K
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1206-10. PubMed ID: 11302744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEN1 gene and its mutations: basic and clinical implications.
    Tsukada T; Nagamura Y; Ohkura N
    Cancer Sci; 2009 Feb; 100(2):209-15. PubMed ID: 19068082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
    Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
    Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia type 1 interacts with forkhead transcription factor CHES1 in DNA damage response.
    Busygina V; Kottemann MC; Scott KL; Plon SE; Bale AE
    Cancer Res; 2006 Sep; 66(17):8397-403. PubMed ID: 16951149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression.
    La P; Desmond A; Hou Z; Silva AC; Schnepp RW; Hua X
    Oncogene; 2006 Jun; 25(25):3537-46. PubMed ID: 16449969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
    Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
    Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-beta pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice.
    Hussein N; Lu J; Casse H; Fontanière S; Morera AM; Guittot SM; Calender A; Di Clemente N; Zhang CX
    Endocr Relat Cancer; 2008 Mar; 15(1):217-27. PubMed ID: 18310289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.